FDA Oncology Announcements

Announcements Trials

Anti-RANKL × Breast × Clear all

Conditions

Breast 1 Genitourinary 1 Plasma cell 1 Sarcoma 1

Drug Classes

Anti-HER2 13 CDK inhibitor 10 Anti-HER2 ADC 8 Anti-PD-1 7 Estrogen receptor inhibitor 7 ERBB2 inhibitor 6 Taxane 5 Anti-TACSTD2 ADC 4 PARP inhibitor 3 Anti-VEGFR 2 Aromatase inhibitor third generation 2 Fluoropyrimidine 2 MTOR inhibitor 2 Non-taxane microtubule dynamics inhibitor 2 PI3K alpha inhibitor 2 TRK inhibitor 2 AKT1 inhibitor 1 Anti-PD-L1 1 Anti-RANKL 1 Anti-TROP2 ADC 1 BRAF inhibitor 1 MEK inhibitor 1 RET inhibitor 1 ROS1 inhibitor 1 Selective estrogen receptor modulator 1

1 Announcement

Denosumab (Prolia)

Drug: Prolia (denosumab) · Anti-RANKL antibody
Conditions: BreastGenitourinary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡